LIPELLA PHARMACEUTICALS INC. financial data

Symbol
LIPO on OTC
Location
Pittsburgh, PA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 444% % -11%
Debt-to-equity 33% % 33%
Return On Equity -208% % -8.4%
Return On Assets -157% % -1.6%
Operating Margin -1190% % -42%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,620,837 shares 282%
Common Stock, Shares, Outstanding 4,620,837 shares 323%
Entity Public Float $2,623,126 USD -73%
Common Stock, Value, Issued $462 USD 324%
Weighted Average Number of Shares Outstanding, Basic 4,549,120 shares 306%
Weighted Average Number of Shares Outstanding, Diluted 4,549,120 shares 306%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $470,163 USD -7.3%
Research and Development Expense $3,568,365 USD 19%
General and Administrative Expense $2,231,378 USD 21%
Operating Income (Loss) $5,409,960 USD -24%
Nonoperating Income (Expense) $80,201 USD -16%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $5,329,759 USD -25%
Net Income (Loss) Attributable to Parent $5,329,759 USD -25%
Earnings Per Share, Basic -2 USD/shares 67%
Earnings Per Share, Diluted -2 USD/shares 67%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,855,771 USD 37%
Accounts Receivable, after Allowance for Credit Loss, Current $84,713 USD 162%
Assets, Current $2,079,288 USD -0.03%
Property, Plant and Equipment, Net $7,699 USD -27%
Operating Lease, Right-of-Use Asset $262,823 USD 278%
Assets $2,349,810 USD 8.8%
Accounts Payable, Current $462,892 USD 0.75%
Accrued Liabilities, Current $34,938 USD -61%
Liabilities, Current $642,399 USD -8.4%
Operating Lease, Liability, Noncurrent $219,816 USD
Liabilities $862,215 USD 23%
Retained Earnings (Accumulated Deficit) $19,228,194 USD -38%
Stockholders' Equity Attributable to Parent $1,487,595 USD 2%
Liabilities and Equity $2,349,810 USD 8.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,426,126 USD -2.7%
Net Cash Provided by (Used in) Financing Activities $3,466,275 USD 1633%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 4,620,837 shares 323%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,855,770 USD 37%
Interest Paid, Excluding Capitalized Interest, Operating Activities $4,152 USD -33%
Deferred Tax Assets, Valuation Allowance $4,218,094 USD 48%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $4,218,094 USD 48%
Operating Lease, Liability $23,797 USD 45%
Operating Lease, Liability, Current $44,267 USD -38%
Deferred Tax Assets, Operating Loss Carryforwards $1,792,928 USD 55%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Additional Paid in Capital $20,715,326 USD 35%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $722 USD 0.14%
Operating Leases, Future Minimum Payments Due $311,043 USD 327%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%